Integration of Risk Evaluation in Cardiovascular Disease Management Programs.

将风险评估纳入心血管疾病管理计划。

• 批准号: nhmrc : 519823
• 负责人: Prof David Thompson
• 金额: $ 344.21万
• 依托单位: Baker IDI Heart and Diabetes Institute
• 依托单位国家: 澳大利亚
• 项目类别: Programs
• 财政年份: 2009
• 资助国家: 澳大利亚
• 起止时间: 2009-01-01 至 2013-12-31
• 项目状态: 已结题
• 来源: https://researchdata.edu.au/integration-risk-evaluation-management-programs/97668
• 关键词: Integration; Risk; Evaluation; Cardiovascular; Disease

This study will determine the feasibility of a coordinated health care team approach to the treatment of cardiovascular disorders. It will examine a range of issues – who would most benefit from this approach, its value for money, the relative importance of health care services to consumers, and where to invest additional health funds. Built on strong collaborations between expert researchers in advanced diagnostic techniques, coordinated health care, community health care and health economics, this provides a unique opportunity to benefit millions of Australians.

这项研究将确定一个协调的医疗保健团队的方法来治疗心血管疾病的可行性。它将研究一系列问题-谁将从这种方法中受益最多，其资金价值，卫生保健服务对消费者的相对重要性，以及在哪里投资额外的卫生资金。建立在先进诊断技术、协调医疗保健、社区医疗保健和卫生经济学专家研究人员之间的强有力合作基础上，这为数百万澳大利亚人提供了一个独特的机会。